Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors (Q41189151)

28 September 2017

1 reference

title

Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors (English)

1 reference

28 September 2017

Lamond JP

1

1 reference

28 September 2017

Wang M

series ordinal

2

1 reference

28 September 2017

Kinsella TJ

series ordinal

3

1 reference

28 September 2017

Boothman DA

series ordinal

4

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

International Journal of Radiation Oncology Biology Physics

28 September 2017

published in

1 reference

28 September 2017

volume

36

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

369-376

1 reference

Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Anticarcinogenic potential of DNA-repair modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Interaction of topoisomerase I inhibitors with radiation in cis-diamminedichloroplatinum(II)-sensitive and -resistant cells in vitro and in the FSAIIC fibrosarcoma in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

The S-phase cytotoxicity of camptothecin.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Trypanosoma cruzi: Ultrastructural and metabolic alterations of epimastigotes by β-lapachone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Potentiation of radiation response in human carcinoma cells in vitro and murine fibrosarcoma in vivo by topotecan, an inhibitor of DNA topoisomerase I

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

The inhibition of cellular recovery in human tumour cells by inhibitors of topoisomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

Inhibition of potentially lethal and sublethal damage repair by camptothecin and etoposide in human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

The current status of camptothecin analogues as antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900326-4

7 January 2021

10.1016/S0360-3016(96)00326-4

Identifiers

DOI

1 reference

28 September 2017

1 reference